Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/huVl5qZPaOI   Two doses of the Novavax full length CoVid spike protein-nano particle vaccine induced significantly high and effective titers of IgG anti-CoVid antibody.  Novavax Inc. has just published these results on the pre-publication online server medrixiv.org.   A total of 1256 participants at 17 sites in the US and Australia completed the blinded, randomized study that tested 2 concentrations of the vaccine in 1 and 2 dose regimens.  The 2 doses employing 5 ug of vaccine triggered the highest levels of antibody with the lowest numbers of side effects.   This vaccine now moves on to Phase 3 testing before it can be presented to the FDA for an emergency use authorization.   https://www.medrxiv.org/content/10.1101/2021.02.26.21252482v1.full.pdf+html   #CoVid #novavax #vaccine #nanoparticle